{"id":"W1740796324","doi":"10.1111/j.1755-5922.2011.00281.x","title":"The Future of Anticoagulant Therapy","year":2011,"lang":"en","type":"editorial","venue":"Cardiovascular Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Dabigatran; Fondaparinux; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Ximelagatran; Intensive care medicine; Vitamin K antagonist; Anticoagulant; Warfarin; Atrial fibrillation; Pharmacology; Surgery; Thrombosis; Thrombin; Internal medicine; Venous thromboembolism","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005499347,0.0009333889,0.001337245,0.001568753,0.0009941875,0.006281452,0.001446331,0.005932832,0.02545347],"category_scores_gemma":[0.01108381,0.0002276594,0.0006477025,0.001017396,0.00426697,0.005195102,0.002233866,0.008134475,0.008966723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003090738,"about_ca_system_score_gemma":0.005120981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009638288,"about_ca_topic_score_gemma":0.001276104,"domain_scores_codex":[0.9960338,0.001303572,0.0002715421,0.0005283176,0.001614895,0.0002478335],"domain_scores_gemma":[0.9937488,0.002537874,0.0005190757,0.0003486433,0.001581948,0.001263663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001175946,0.00009899429,0.0006129658,0.001217283,0.0000562078,0.0002545845,0.0002765704,0.0003479112,0.0005569802,0.1330721,0.3621662,0.5012226],"study_design_scores_gemma":[0.00001576693,0.00005987359,0.0002218513,0.001104937,0.00001094992,0.00040312,0.00007592632,0.00008110653,0.00006539012,0.02687525,0.9710729,0.00001294229],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.0006399258,0.7076592,0.003417872,0.2135338,0.02363359,0.00002486781,0.0001781644,0.0001496177,0.05076291],"genre_scores_gemma":[0.02034269,0.8043629,0.004926852,0.08111463,0.05352299,0.0001017933,0.0003099309,0.00009567296,0.03522256],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02545347,"threshold_uncertainty_score":0.08515036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06203925275111086,"score_gpt":0.3132001269455031,"score_spread":0.2511608741943923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}